Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CATALYST pediatric RR-TB clofazimine and moxifloxacin PK study
PACTR202012756409365Completed
- Sponsor
- Stellenbosch University
- Start
- Jan 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of clofazimine and moxifloxacin in Tuberculosis (TB), sponsored by Stellenbosch University. Primary endpoint: Pharmacokinetic parameters of moxifloxacin and clofazimine. Started Jan 2021; status: completed.
02
Drugs
clofaziminemoxifloxacin
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on PACTR202012756409365.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202012756409365.